The mortality rate exerted by SARS-CoV-2 is over seven hundred thousand deaths worldwide as of by August 7th. Around 200 possible vaccines are undergoing clinical trials. However, it remains uncertain when will these vaccines be released and we don’t know if these vaccines could be effective for the virus. Here, we propose an “in
silico” multitarget approach, targeting three key proteins (Mpro-RdRp-nsp16/10) in the propagation of SARS-CoV-2.

Multitarget approach for designing compounds with potential activity against SARS-CoV-2

LatinXChem

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.